Top

Published in:

01-09-2016 | Lipid and Metabolic Effects of Gastrointestinal Surgery (R. Cohen, Section Editor)

The Bariatric Patient in the Intensive Care Unit: Pitfalls and Management

Authors: Carlos E. Pompilio, Paolo Pelosi, Melina G. Castro

Published in: Current Atherosclerosis Reports | Issue 9/2016

Abstract

The increasing number of bariatric/metabolic operations as important alternatives for the treatment of obesity and type 2 diabetes brought several concerns about the intensive care of patients undergoing those procedures. Intensive Care Unit admission criteria are needed in order to better allocate resources and avoid unnecessary interventions. Furthermore, well-established protocols, helpful in many clinical situations, are not directly applicable to obese patients. Indeed, difficult airway management, mechanical ventilation, fluid therapy protocols, prophylaxis, and treatment of venous thromboembolic events have unique aspects that should be taken into consideration. Finally, new data related to planning nutrition therapy of the critically obese have been highlighted and deserve consideration. In this review, we provide an outline of recent studies related to those important aspects of the care of the bariatric/metabolic patients in critical conditions.

Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–81.CrossRefPubMedPubMedCentral

Halperin F, Goldfine AB. Metabolic surgery for type 2 diabetes: efficacy and risks. Curr Opin Endocrinol Diabetes Obes. 2013;20(2):98–105.CrossRefPubMed

Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.CrossRefPubMed

Inge TH, Courcoulas AP, Jenkins TM, Michalsky MP, Helmrath MA, Brandt ML, et al. Weight loss and health status 3 years after bariatric surgery in adolescents. N Engl J Med. 2016;374(2):113–23.CrossRefPubMed

Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation. 1983;67(5):968–77.CrossRefPubMed

Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341(15):1097–105.CrossRefPubMed

7.••

The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014;383(9921):970–83. Large study designed to identify how much of the effects of BMI on coronary heart disease and stroke are mediated through blood pressure, cholesterol, and glucose, and how much is independent of these factors. CrossRef

Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012;31(1):219–30.CrossRefPubMed

Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.CrossRefPubMed

10.

Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.CrossRefPubMed

11.

Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294(15):1909–17.CrossRefPubMed

12.

Flum DR, Salem L, Elrod JAB, Dellinger EP, Cheadle A, Chan L. Early mortality among medicare beneficiaries undergoing bariatric surgical procedures. JAMA. 2005;294(15):1903–8.CrossRefPubMed

13.

Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142(4):621–32. discussion 632–5.CrossRefPubMed

14.

Morino M, Toppino M, Forestieri P, Angrisani L, Allaix ME, Scopinaro N. Mortality after bariatric surgery. Ann Surg. 2007;246(6):1002–9.CrossRefPubMed

15.

Nguyen NT, Masoomi H, Laugenour K, Sanaiha Y, Reavis KM, Mills SD, et al. Predictive factors of mortality in bariatric surgery: data from the nationwide inpatient sample. Surgery. 2011;150(2):347–51.CrossRefPubMed

16.•

Chang S-H, Stoll CRT, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149(3):275–87. Systematic review about the impact of bariatric / metabolic surgery on controlling risk factors. CrossRefPubMedPubMedCentral

17.

Steiner CA, Bass EB, Talamini MA, Pitt HA, Steinberg EP. Surgical rates and operative mortality for open and laparoscopic cholecystectomy in Maryland. N Engl J Med. 1994;330(6):403–8.CrossRefPubMed

18.

Blomqvist PG, Andersson RE, Granath F, Lambe MP, Ekbom AR. Mortality after appendectomy in Sweden, 1987–1996. Ann Surg. 2001;233(4):455–60.CrossRefPubMedPubMedCentral

19.

Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–32.CrossRefPubMed

20.

Morgan D, Ho KM. The anaesthetic assessment, management and risk factors of bariatric surgical patients requiring postoperative intensive care support: a state-wide, five-year cohort study. Anaesth Intensive Care. 2016;44(2):237–44.PubMed

21.

Morgan DJR, Ho KM, Armstrong J, Baker S. Incidence and risk factors for intensive care unit admission after bariatric surgery: a multicentre population-based cohort study. Br J Anaesth. 2015;115(6):873–82.CrossRef

22.

Froylich D, Corcelles R, Davis M, Boules M, Daigle CR, Schauer PR, et al. Factors associated with length of stay in intensive care after bariatric surgery. SOARD. 2016;21:1–6.

23.

Goulenok C, Monchi M, Chiche JD. Influence of overweight on ICU mortality: a prospective study. Chest. 2004;125:1441–5.CrossRefPubMed

24.

Tsai A, Schumann R. Morbid obesity and perioperative complications. Curr Opin Anaesthesiol. 2016;29(1):103–8.CrossRefPubMed

25.

Akinnusi ME, Pineda LA, El-Solh AA. Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med. 2008;36(1):151–8.CrossRefPubMed

26.

Sakr Y, Alhussami I, Nanchal R, Wunderink RG, Pellis T, Wittebole X, et al. Being overweight is associated with greater survival in ICU patients. Crit Care Med. 2015;43(12):2623–32.CrossRef

27.

Anzueto A, Frutos-Vivar F, Esteban A, Bensalami N, Marks D, Raymondos K, et al. Influence of body mass index on outcome of the mechanically ventilated patients. Thorax. 2011;66(1):66–73.CrossRefPubMed

28.

Fernandez Jr AZ, Demaria EJ, Tichansky DS, Kellum JM, Wolfe LG, Meador J, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004;239(5):698–703.CrossRefPubMedPubMedCentral

29.

Goucham AB, Coblijn UK, Hart-Sweet HB, Vries N, Lagarde SM, Wagensveld BA. Routine postoperative monitoring after bariatric surgery in morbidly obese patients with severe obstructive sleep apnea: ICU admission is not necessary. Obes Surg. 2016;17:1–6.

30.

Nguyen NT, Nguyen B, Smith B, Reavis KM, Elliott C, Hohmann S. Proposal for a bariatric mortality risk classification system for patients undergoing bariatric surgery. SOARD. 2013;9(2):239–46.

31.

Gardner-Thorpe J, Love N, Wrightson J, Walsh S, Keeling N. The value of Modified Early Warning Score (MEWS) in surgical in-patients: a prospective observational study. Ann R Coll Surg Engl. 2006;88(6):571–5.CrossRefPubMedPubMedCentral

32.

Bluth T, Pelosi P, de Abreu MG. The obese patient undergoing nonbariatric surgery. Curr Opin Anaesthesiol. 2016 Mar:1–9.

33.

Cook TM, Woodall N, Frerk C. Fourth national audit project. Major complications of airway management in the UK: results of the fourth national audit project of the Royal College of Anaesthetists and the difficult airway Society. Part 1: anaesthesia. Br J Anaesth. 2011;106(5):617–31.CrossRefPubMed

34.

Kheterpal S, Healy D, Aziz MF, Shanks AM, Freundlich RE, Linton F, et al. Incidence, predictors, and outcome of difficult mask ventilation combined with difficult laryngoscopy a report from the multicenter perioperative outcomes group. Anesthesiology. 2013;119(6):1360–9.CrossRefPubMed

35.

Leoni A, Arlati S, Ghisi D, Verwej M, Lugani D, Ghisi P, et al. Difficult mask ventilation in obese patients: analysis of predictive factors. Minerva Anestesiol. 2014;80(2):149–57.PubMed

36.

Cattano D, Killoran PV, Cai C, Katsiampoura AD, Corso RM, Hagberg CA. Difficult mask ventilation in general surgical population: observation of risk factors and predictors. F1000Res. 2014;3:204.PubMedPubMedCentral

37.

Acar HV, Yarkan Uysal H, Kaya A, Ceyhan A, Dikmen B. Does the STOP-Bang, an obstructive sleep apnea screening tool, predict difficult intubation? Eur Rev Med Pharmacol Sci. 2014;18(13):1869–74.PubMed

38.

De Jong A, Molinari N, Pouzeratte Y, Verzilli D, Chanques G, Jung B, et al. Difficult intubation in obese patients: incidence, risk factors, and complications in the operating theatre and in intensive care units. Br J Anaesth. 2015;114(2):297–306.CrossRefPubMed

39.•

el-Ganzouri AR, McCarthy RJ, Tuman KJ, Tanck EN, Ivankovich AD. Preoperative airway assessment: predictive value of a multivariate risk index. Anesth Analg. 1996;82(6):1197–204. Describes a useful composed airway risk index that improves difficult airway stratification. PubMed

40.

Pelosi P, Quintel M, Malbrain MLNG. Effect of intra-abdominal pressure on respiratory mechanics. Acta Clin Belg. 2007;62 Suppl 1:78–88.CrossRef

41.

Aldenkortt M, Lysakowski C, Elia N, Brochard L, Tramer MR. Ventilation strategies in obese patients undergoing surgery: a quantitative systematic review and meta-analysis. Br J Anaesth. 2012;109(4):493–502.CrossRefPubMed

42.

Jaber S, Coisel Y, Chanques G, Futier E, Constantin JM, Michelet P, et al. A multicentre observational study of intra-operative ventilatory management during general anaesthesia: tidal volumes and relation to body weight. Anaesthesia. 2012;67(9):999–1008.CrossRefPubMed

43.

Lellouche F, Dionne S, Simard S, Bussières J, Dagenais F. High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery. Anesthesiology. 2012;116(5):1072–82.CrossRefPubMed

44.

Serpa Neto A, Cardoso SO, Manetta JA, Pereira VGM, Espósito DC, Mde Pasqualucci O, et al. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA. 2012;308(16):1651–9.CrossRefPubMed

45.

Serpa Neto A, Hemmes SNT, Barbas CSV, Beiderlinden M, Biehl M, Binnekade JM, et al. Protective versus conventional ventilation for surgery: a systematic review and individual patient data meta-analysis. Anesthesiology. 2015;123(1):66–78.CrossRefPubMed

46.

Serpa Neto A, Hemmes SNT, Barbas CSV, Beiderlinden M, Fernandez-Bustamante A, MD PEF, et al. Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data. Lancet Respir. 2016;2:1–9.

47.

Severgnini P, Selmo G, Lanza C, Chiesa A, Frigerio A, Bacuzzi A, et al. Protective mechanical ventilation during general anesthesia for open abdominal surgery improves postoperative pulmonary function. Anesthesiology. 2013;118(6):1307–21.CrossRefPubMed

48.

Futier E, Constantin J-M, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369(5):428–37.CrossRefPubMed

49.

PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthesiology, Hemmes SNT, Gama De Abreu M, Pelosi P, Schultz MJ. High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet. 2014;384(9942):495–503.CrossRef

50.•

Pelosi P, Ravagnan I, Giurati G, Panigada M, Bottino N, Tredici S, et al. Positive end-expiratory pressure improves respiratory function in obese but not in normal subjects during anesthesia and paralysis. Anesthesiology. 1999;91(5):1221–31. Paper showing positive PEEP effects improving ventilatory function in morbidly obese. CrossRefPubMed

51.

Reinius H, Jonsson L, Gustafsson S, Sundbom M, Duvernoy O, Pelosi P, et al. Prevention of atelectasis in morbidly obese patients during general anesthesia and paralysis: a computerized tomography study. Anesthesiology. 2009;111(5):979–87.CrossRefPubMed

52.•

Wang C, Zhao N, Wang W, Guo L, Guo L, Chi C, et al. Intraoperative mechanical ventilation strategies for obese patients: a systematic review and network meta-analysis. Obes Rev. 2015;16(6):508–17. Metanalysis of 13 studies comparing different intraoperative ventilatory strategies in obese. CrossRefPubMed

53.

Pirrone M, Fisher D, Chipman D, Imber DAE, Corona J, Mietto C, et al. Recruitment maneuvers and positive end-expiratory pressure titration in morbidly obese ICU patients. Crit Care Med. 2016;44(2):300–7.CrossRefPubMed

54.

Whalen FX, Gajic O, Thompson GB, Kendrick ML, Que FL, Williams BA, et al. The effects of the alveolar recruitment maneuver and positive end-expiratory pressure on arterial oxygenation during laparoscopic bariatric surgery. Anesth Analg. 2006;102(1):298–305.CrossRefPubMed

55.

Defresne AA, Hans GA, Goffin PJ, Bindelle SP, Amabili PJ, DeRoover AM, et al. Recruitment of lung volume during surgery neither affects the postoperative spirometry nor the risk of hypoxaemia after laparoscopic gastric bypass in morbidly obese patients: a randomized controlled study. Br J Anaesth. 2014;113(3):501–7.CrossRefPubMed

56.

Baltieri L, Santos LA, Rasera I, Montebelo MIL, Pazzianotto-Forti EM. Use of positive pressure in the bariatric surgery and effects on pulmonary function and prevalence of atelectasis: randomized and blinded clinical trial. Arq Bras Cir Dig. 2014;27 Suppl 1:26–30.CrossRefPubMedPubMedCentral

57.

Bohm SH, Thamm OC, von Sandersleben A, Bangert K, Langwieler TE, Tusman G, et al. Alveolar recruitment strategy and high positive end-expiratory pressure levels do not affect hemodynamics in morbidly obese intravascular volume-loaded patients. Anesth Analg. 2009;109(1):160–3.CrossRefPubMed

58.

Canet J, Belda FJ. Perioperative hyperoxia: the debate is only getting started. Anesthesiology. 2011;114(6):1271–3.CrossRefPubMed

59.

Staehr AK, Meyhoff CS, Rasmussen LS. PROXI Trial Group. Inspiratory oxygen fraction and postoperative complications in obese patients: a subgroup analysis of the PROXI trial. Anesthesiology. 2011;114(6):1313–9.CrossRefPubMed

60.

Hedenstierna G. Oxygen and anesthesia: what lung do we deliver to the post-operative ward? Acta Anaesthesiol Scand. 2012;56(6):675–85.CrossRefPubMed

61.••

Pelosi P, Gregoretti C, Pelosi P, Gregoretti C. Perioperative management of obese patients. Best Pract Res Clin Anaesthesiol. 2010;24(2):211–25. Recent review on ventilatory and anesthetic aspects of obese patient. CrossRefPubMed

62.

Carrara FSA, Zanei SSV, Cremasco MF, Whitaker IY. Outcomes and nursing workload related to obese patients in the intensive care unit. Intensive Crit Care Nurs. Elsevier Ltd; 2016 Jan 23:1–7.

63.

Fagevik Olsén M, Hahn I, Nordgren S, Lönroth H, Lundholm K. Randomized controlled trial of prophylactic chest physiotherapy in major abdominal surgery. Br J Surg. 1997;84(11):1535–8.CrossRefPubMed

64.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.CrossRefPubMedPubMedCentral

65.

Hans GA, Lauwick S, Kaba A, Brichant J-F, Joris JL. Postoperative respiratory problems in morbidly obese patients. Acta Anaesthesiol Belg. 2009;60(3):169–75.PubMed

66.

Carron M, Zarantonello F, Tellaroli P, Ori C. Perioperative noninvasive ventilation in obese patients: a qualitative review and meta-analysis. SOARD. 2016 Feb 29:1–11.

67.

Hollier CA, Harmer AR, Maxwell LJ, Menadue C, Willson GN, Unger G, et al. Moderate concentrations of supplemental oxygen worsen hypercapnia in obesity hypoventilation syndrome: a randomised crossover study. Thorax. 2014;69(4):346–53.CrossRefPubMed

68.

Povitz M, Hanly PJ, Pendharkar SR, James MT, Tsai WH. Treatment of sleep disordered breathing liberates obese hypoxemic patients from oxygen. Penzel T, editor. PLoS ONE; 2015 Oct 9;10(10):e0140135–11.

69.

Muñoz JL, Gabaldón T, Miranda E, Berrio DL, Ruiz-Tovar J, Ronda JM, et al. Goal-directed fluid therapy on laparoscopic sleeve gastrectomy in morbidly obese patients. Obes Surg. 2016 Mar 19:1–6.

70.

Tosetto A, Frezzato M, Rodeghiero F. Prevalence and risk factors of non-fatal venous thromboembolism in the active population of the VITA Project. J Thromb Haemost. 2003;1(8):1724–9.CrossRefPubMed

71.

Gould MK, Garcia DA, MD SMW, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients. Chest. 2012;141(Supplement):e227S–77.CrossRefPubMedPubMedCentral

72.

Steele KE, Canner J, Prokopowicz G, Verde F, Beselman A, Wyse R, et al. The EFFORT trial: preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial. SOARD. 2015;11(3):672–83.

73.

Bloom MB, Zaw AA, Hoang DM, Mason R, Alban RF, Chung R, et al. Body mass index strongly impacts the diagnosis and incidence of heparin-induced thrombocytopenia in the surgical intensive care unit. J Trauma Acute Care Surg. 2016;80(3):398–404.CrossRefPubMed

74.

Freeman AL, Pendleton RC, Rondina MT. Prevention of venous thromboembolism in obesity. Expert Rev Cardiovasc Ther. 2014;8(12):1711–21.CrossRef

75.

Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51(2–3):70–8.CrossRefPubMed

76.••

Patel JP, Roberts LN, Arya R. Anticoagulating obese patients in the modern era. Br J Haematol. 2011;155(2):137–49. Comprehensive article reviewing the pharmacologic issues on anticoagulation of obese patients. CrossRefPubMed

77.

Ihaddadene R, Carrier M. The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety. Expert Opin Drug Saf. 2015;15(1):65–74.CrossRefPubMed

78.

Gagner M, Selzer F, Belle SH, Bessler M, Courcoulas AP, Dakin GF, et al. Adding chemoprophylaxis to sequential compression might not reduce risk of venous thromboembolism in bariatric surgery patients. SOARD. 2012;8(6):663–70.

79.

Agarwal R, Hecht TEH, Lazo MC, Umscheid CA. Venous thromboembolism prophylaxis for patients undergoing bariatric surgery: a systematic review. SOARD. 2010;6(2):213–20.

80.

Birkmeyer NJO, Finks JF, Carlin AM, Chengelis DL, Krause KR, Hawasli AA, et al. Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery. Arch Surg. 2012;147(11):994–8.CrossRefPubMed

81.

Becattini C, Agnelli G, Manina G, Noya G, Rondelli F. Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention. SOARD. 2012;8(1):108–15.

82.

Fowler RA, Mittmann N, Geerts W, Heels-Ansdell D, Gould MK, Guyatt G, et al. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients. JAMA. 2014;312(20):2135–11.CrossRefPubMed

83.

Clements RH, Yellumahanthi K, Ballem N, Wesley M, Bland KI. Pharmacologic prophylaxis against venous thromboembolic complications is not mandatory for all laparoscopic Roux-en-Y gastric bypass procedures. J Am Coll Surg. 2009;208(5):917–21.CrossRefPubMed

84.

Frantzides CT, Welle SN, Ruff TM, Frantzides AT. Routine anticoagulation for venous thromboembolism prevention following laparoscopic gastric bypass. JSLS. 2012;16(1):33–7.CrossRefPubMedPubMedCentral

85.

Hamad GG, Bergqvist D. Venous thromboembolism in bariatric surgery patients: an update of risk and prevention. SOARD. 2007;3(1):97–102.

86.

Magee CJ, Barry J, Javed S, Macadam R, Kerrigan D. Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery. SOARD. 2016;6(3):322–5.

87.••

Aminian A, Andalib A, Khorgami Z, Cetin D, Burguera B, Bartholomew J, et al. Who should get extended thromboprophylaxis after bariatric surgery? Ann Surg. 2016 Mar :1–8 (epub ahead). Interesting and recent paper about extended prophylaxis in bariatric patients.

88.

Finks SW, Trujillo TC, Dobesh PP. Management of venous thromboembolism: recent advances in oral anticoagulation therapy. Ann Pharmacother. 2016 Feb 25:1–16.

89.

Samama M-M, Amiral J, Guinet C, Flem LL, Seghatchian J. Monitoring plasma levels of factor Xa inhibitors: how, why and when? Expert Rev Hematol. 2014;6(2):155–64.CrossRef

90.

Rajasekhar A, Crowther M. Inferior vena caval filter insertion prior to bariatric surgery: a systematic review of the literature. J Thromb Haemost. 2010;8(6):1266–70.CrossRefPubMed

91.••

Mechanick JI, Youdim A, Jones DB, Timothy Garvey W, Hurley DL, Molly McMahon M, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American association of clinical endocrinologists, the obesity society, and American society for metabolic & bariatric surgery. SOARD. 2013;9(2):159–91. Guidelines on care of bariatric / metabolic patients.

92.

Raslan M, Gonzalez MC, Torrinhas RSMM, Ravacci GR, Pereira JCR, Waitzberg DL. Complementarity of subjective global assessment (SGA) and nutritional risk screening 2002 (NRS 2002) for predicting poor clinical outcomes in hospitalized patients. Clin Nutr. 2011;30(1):49–53.CrossRefPubMed

93.

Rahman A, Hasan RM, Agarwala R, Martin C, Day AG, Heyland DK. Identifying critically-ill patients who will benefit most from nutritional therapy: further validation of the “modified NUTRIC” nutritional risk assessment tool. Clin Nutr. 2016;35(1):158–62.CrossRefPubMed

94.

McClave SA, Martindale RG, Kiraly L. The use of indirect calorimetry in the intensive care unit. Curr Opin Clin Nutr Metab Care. 2013;16(2):202–8.CrossRefPubMed

95.

Reeds DN. Nutrition support in the obese, diabetic patient: the role of hypocaloric feeding. Curr Opin Gastroenterol. 2009;25(2):151–4.CrossRef

96.

McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically Ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40(2):159–211.CrossRefPubMed

97.

McClave SA, Kushner R, Van Way CW, Cave M, DeLegge M, Dibaise J, et al. Nutrition therapy of the severely obese, critically ill patient: summation of conclusions and recommendations. JPEN J Parenter Enteral Nutr. 2011;35(5 Suppl):88S–96.CrossRefPubMed

98.

Choban PS, Burge JC, Scales D, Flancbaum L. Hypoenergetic nutrition support in hospitalized obese patients: a simplified method for clinical application. Am J Clin Nutr. 1997;66(3):546–50.PubMed

99.

McCowen KC, Friel C, Sternberg J, Chan S, Forse RA, Burke PA, et al. Hypocaloric total parenteral nutrition: effectiveness in prevention of hyperglycemia and infectious complications—a randomized clinical trial. Crit Care Med. 2000;28(11):3606–11.CrossRefPubMed

100.

Palgi A, Read JL, Greenberg I, Hoefer MA, Bistrian BR, Blackburn GL. Multidisciplinary treatment of obesity with a protein-sparing modified fast: results in 668 outpatients. Am J Public Health. 1985;75(10):1190–4.CrossRefPubMedPubMedCentral

101.

Hurt RT, Frazier TH, McClave SA, Cave MC. Pharmaconutrition for the obese, critically ill patient. JPEN J Parenter Enteral Nutr. 2011;35(5 Suppl):60S–72.CrossRefPubMed

102.

Pennings B, Boirie Y, Senden JMG, Gijsen AP, Kuipers H, van Loon LJC. Whey protein stimulates postprandial muscle protein accretion more effectively than do casein and casein hydrolysate in older men. Am J Clin Nutr. 2011;93(5):997–1005.CrossRefPubMed

103.

Marik PE. Feeding critically ill patients the right “whey”: thinking outside of the box. A personal view. Ann Intensive Care. 2015 Jun 5:1–8.

Title: The Bariatric Patient in the Intensive Care Unit: Pitfalls and Management
Authors: Carlos E. Pompilio
Paolo Pelosi
Melina G. Castro
Publication date: 01-09-2016
Publisher: Springer US
Published in: Current Atherosclerosis Reports / Issue 9/2016
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI: https://doi.org/10.1007/s11883-016-0606-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The Bariatric Patient in the Intensive Care Unit: Pitfalls and Management

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2016

Targeting ApoC-III to Reduce Coronary Disease Risk

The Role of Intracoronary Plaque Imaging with Intravascular Ultrasound, Optical Coherence Tomography, and Near-Infrared Spectroscopy in Patients with Coronary Artery Disease

Erratum to: Endovascular Interventions in Acute Ischemic Stroke: Recent Evidence, Current Challenges, and Future Prospects

A Contemporary Approach to Pulmonary Arterial Hypertension

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page